Startups

March Biosciences
Develops CAR-T cell therapies for cancers with limited treatment options, including a CD5-targeted program for T-cell malignancies.
Startups

Develops CAR-T cell therapies for cancers with limited treatment options, including a CD5-targeted program for T-cell malignancies.